English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new field of forensics is being proposed by research integrity experts to recognize their investigations into unscrupulous research behavior and misuse of scholarship: Forensic Scientometrics.
Tag: Analysis
First Mutation-Targeted Bladder Cancer Drug May Be Under-Used
The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a JAMA Oncology study led by the University of Pennsylvania. Researchers analyzed a large, nationwide database of cancer cases and found that bladder cancer patients potentially eligible for erdafitinib (Balversa) treatment, fewer than half had a record of being tested for the relevant gene mutation. Of those who were tested and found to have the mutation, fewer than half received the treatment.
MAPPING COVID RISK IN URBAN AREAS: A WAY TO KEEP THE ECONOMY OPEN
As COVID-19 vaccines slowly roll out across the world, government officials in densely populated countries must still manage vulnerable communities at highest risk of an outbreak. In a new study published in the journal Risk Analysis, researchers in India propose a COVID Risk Assessment and Mapping (CRAM) framework that results in a zoned map that officials can use to place more targeted restrictions on high-risk communities. Successfully used by officials in Jaipur at the peak of the pandemic last spring, their framework could help other vulnerable countries avoid a shutdown of their regional economies.
Smartphones prove to be time-saving analytical tools
Scientists use a smartphone camera to easily measure soil density — a key metric for analyzing our soils
August’s Special Issue of SLAS Technology “Carbohydrate Structure Analysis: Methods and Application” Available Now
The August edition of SLAS Technology “Carbohydrate Structure Analysis: Methods and Application” is curated by guest editors Christian Heiss, Ph.D. and Parastoo Azadi, Ph.D., of the University of Georgia’s Complex Carbohydrate Research Center.
Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows
A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase Clinical Trials and Chief of Melanoma at Roswell Park Comprehensive Cancer Center and published today in the journal JAMA Oncology provides new insights into an important question: whether BRAF V600E/K mutation status or previous BRAF inhibitor (BRAFi) therapy with or without a MEK inhibitor (MEKi) affects response to pembrolizumab (brand name Keytruda) in patients with advanced melanoma.
23 Years of Water Quality Data from Crop-Livestock Systems
Researchers summarize runoff water quantity and quality data from native tallgrass prairie and crop-livestock systems in Oklahoma between 1977 and 1999